Yuyu Pharmaceutical establishes US subsidiary to develop health foods and medicines for cats (Korean media report)

Pharmaceutical company YuYu Pharmaceuticals has announced that it will invest $4.5 million (USD, approximately 700 million yen) to establish a US-based corporation, YuYu Ventures.
This follows the startup investment made in April in a pet-related business in the United States.
Char is a holding company that controls two companies: Yuyu Bio and Mervyn's Petcare.
Yuyu Bio is engaged in the pet biopharmaceutical business and is developing biopharmaceuticals with special features such as long-lasting effects.
Meanwhile, Marvin's Petcare is in the pet health food business, developing joint and skin care products and multivitamins for cats.
YuYu Bio and Marvin's Petcare are partnering with the California NanoSystems Institute (CNSI) to develop a nanotechnology-based nanotechnology platform.
The company passed the screening process for a startup development program and has an office on the campus of the University of California. Yuyu Pharmaceutical says, "In the United States, we have seen that cat-related products have particularly high growth potential.
"We understand this, and for this reason, YuYu Bio and Marvin's Petcare will focus on biopharmaceuticals and health foods for cats."
After that, they plan to develop a pet business in the US, and continue to expand their business through corporate acquisitions.